Form D · Venture Capital Fund

JSL PrecisionNeuro a Series of JSL Health Capital SPV LLC

Claymont, DE · CIK 0002103656

Offering snapshot reported Feb 24, 2026 · SEC filing

Reported sold
$1.7M
Offering amount: $1.7M
Investors reported
4
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Jan 5, 2026
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$849K$1.7MJan 6, 2026: $1,493,389.00Jan 6, 2026Feb 24, 2026: $1,698,337.00Feb 24, 2026

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$1,493,389 → $1,698,337
  • Reported investors3 → 4

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Feb 24, 2026Amendment$1,698,337$204,948vs Jan 6, 20264SEC filing
Jan 6, 2026Initial$1,493,389No comparison3SEC filing

Offering details

Securities
Pooled investment fund
Exemptions
06b, 3C, 3C.1
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-569003

Source: Form D, filed Feb 24, 2026. Minimum accepted may differ from a standard advertised minimum.

Fund connections

The linked fund shows its most recently reported ADV details.

Matched by reported Form D file number

JSL PRECISIONNEURO, A SERIES OF JSL HEALTH CAPITAL SPV, LLC

Investment adviser: JSL HEALTH CAPITAL MANAGEMENT, LLC

Gross asset value
$1.68M
Beneficial owners
4
ADV minimum commitment
$50K

Reported in Form ADV on May 6, 2026. Fund assets and beneficial owners measure different things from Form D sales and investors.

Service providers

Fund administrator SYDECAR, LLC CLAYMONT, Delaware, United States Investor statements: Yes (provided to all investors) Related to adviser: No
Custodian GRASSHOPPER BANK N.A. NEW YORK, New York, United States Related to adviser: No
Provider details
Annual audit
No
Prime brokers
No
Custodians
Yes
Administrator other than the adviser
Yes
External marketing
No
Filing source

Form ADV 2102614 · May 6, 2026 · Schedule D 7.B.(1), fund 805-5812128974

Official IAPD profile (latest public filing). Values are the most recently reported in our imported data; the public profile may show a newer filing.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Brett Sagan Executive
Llc Sydecar Director

Issuer details

Industry: Pooled Investment Fund (See others in industry)

Address:
2093 Philadelphia Pike 5885
Claymont, DE, 19703